Risk of Severe COVID–19 Outcomes Among Patients with Rheumatoid Arthritis in the United States
View ORCID ProfileChing-Yi Chuo, View ORCID ProfileVince Yau, Sriraman Madhavan, View ORCID ProfileLarry Tsai, View ORCID ProfileJenny Chia
doi: https://doi.org/10.1101/2021.07.09.21260106
Ching-Yi Chuo
1Personalized Health Care, Genentech, South San Francisco, United States
Vince Yau
1Personalized Health Care, Genentech, South San Francisco, United States
Sriraman Madhavan
1Personalized Health Care, Genentech, South San Francisco, United States
Larry Tsai
2Product Development, Genentech, South San Francisco, United States
Jenny Chia
1Personalized Health Care, Genentech, South San Francisco, United States

Article usage
Posted July 12, 2021.
Risk of Severe COVID–19 Outcomes Among Patients with Rheumatoid Arthritis in the United States
Ching-Yi Chuo, Vince Yau, Sriraman Madhavan, Larry Tsai, Jenny Chia
medRxiv 2021.07.09.21260106; doi: https://doi.org/10.1101/2021.07.09.21260106
Subject Area
Subject Areas
- Addiction Medicine (422)
- Allergy and Immunology (746)
- Anesthesia (217)
- Cardiovascular Medicine (3215)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13229)
- Forensic Medicine (19)
- Gastroenterology (887)
- Genetic and Genomic Medicine (5050)
- Geriatric Medicine (469)
- Health Economics (772)
- Health Informatics (3173)
- Health Policy (1126)
- Hematology (421)
- HIV/AIDS (998)
- Medical Education (467)
- Medical Ethics (125)
- Nephrology (513)
- Neurology (4794)
- Nursing (253)
- Nutrition (712)
- Oncology (2469)
- Ophthalmology (699)
- Orthopedics (278)
- Otolaryngology (336)
- Pain Medicine (319)
- Palliative Medicine (89)
- Pathology (528)
- Pediatrics (1274)
- Primary Care Research (548)
- Public and Global Health (7355)
- Radiology and Imaging (1665)
- Respiratory Medicine (965)
- Rheumatology (472)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (69)
- Transplantation (228)
- Urology (199)